|
PSEN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.769800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.147200E-01 |
| Normal-vs-Stage2 |
1.747760E-01 |
| Normal-vs-Stage3 |
2.387800E-02 |
| Normal-vs-Stage4 |
6.262200E-03 |
| Stage1-vs-Stage2 |
7.070000E-01 |
| Stage1-vs-Stage3 |
1.563830E-01 |
| Stage1-vs-Stage4 |
6.978100E-02 |
| Stage2-vs-Stage3 |
5.235800E-01 |
| Stage2-vs-Stage4 |
2.272200E-01 |
| Stage3-vs-Stage4 |
4.689200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.772000E-02 |
| Normal-vs-AfricanAmerican |
9.314200E-01 |
| Normal-vs-Asian |
3.914800E-01 |
| Caucasian-vs-AfricanAmerican |
2.189200E-01 |
| Caucasian-vs-Asian |
4.464200E-01 |
| AfricanAmerican-vs-Asian |
5.746800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.116200E-02 |
| Normal-vs-Female |
1.218970E-01 |
| Male-vs-Female |
2.579000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.776200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.416100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.724700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.598300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.536100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.555300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.017800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.544800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.845600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.040800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.574000E-02 |
| Classical-VS-Follicular |
9.097800E-03 |
| Classical-VS-Other |
2.080000E-01 |
| Classical-VS-Normal |
3.577000E-01 |
| Tall-VS-Follicular |
9.662600E-01 |
| Tall-VS-Other |
6.472200E-01 |
| Tall-VS-Normal |
2.712500E-02 |
| Follicular-VS-Other |
7.145200E-01 |
| Follicular-VS-Normal |
9.315300E-03 |
| Other-VS-Normal |
8.702100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.812400E-02 |
| Normal-vs-N1 |
2.317800E-02 |
| N0-vs-N1 |
4.022600E-01 |
|
|
